Trabectedin for Soft Tissue Sarcoma: Current Status and Future Perspectives
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Trabectedin for Soft Tissue Sarcoma: Current Status and Future Perspectives
Authors
Keywords
Alkylating agent, Clinical trials, Chemotherapy, DNA minor groove binder, ET-743, Oncology, Soft tissue sarcoma, Trabectedin
Journal
ADVANCES IN THERAPY
Volume 33, Issue 7, Pages 1055-1071
Publisher
Springer Nature
Online
2016-05-27
DOI
10.1007/s12325-016-0344-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial
- (2016) George D. Demetri et al. JOURNAL OF CLINICAL ONCOLOGY
- Trabectedin and its potential in the treatment of soft tissue sarcoma
- (2016) J Fayette Therapeutics and Clinical Risk Management
- Trabectedin in patients with advanced soft tissue sarcoma: A retrospective national analysis of the French Sarcoma Group
- (2015) Axel Le Cesne et al. EUROPEAN JOURNAL OF CANCER
- Beyond clinical trials in advanced soft tissue sarcoma: what to expect from trabectedin treatment?
- (2015) Peter Reichardt Future Oncology
- Trabectedin monotherapy after standard chemotherapy versus best supportive care in patients with advanced, translocation-related sarcoma: a randomised, open-label, phase 2 study
- (2015) Akira Kawai et al. LANCET ONCOLOGY
- Trabectedin in Soft Tissue Sarcomas
- (2015) Bradley Petek et al. Marine Drugs
- Trabectedin, a drug acting on both cancer cells and the tumour microenvironment
- (2014) M D’Incalci et al. BRITISH JOURNAL OF CANCER
- Randomised phase III trial of trabectedin versus doxorubicin-based chemotherapy as first-line therapy in translocation-related sarcomas
- (2014) Jean-Yves Blay et al. EUROPEAN JOURNAL OF CANCER
- Clinical outcomes and safety with trabectedin therapy in patients with advanced soft tissue sarcomas following failure of prior chemotherapy: results of a worldwide expanded access program study
- (2013) B. L. Samuels et al. ANNALS OF ONCOLOGY
- Efficacy and safety of trabectedin as an early treatment for advanced or metastatic liposarcoma and leiomyosarcoma
- (2013) Jean Yves Blay et al. Future Oncology
- Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
- (2012) Winette TA van der Graaf et al. LANCET
- Phase II clinical trial of neoadjuvant trabectedin in patients with advanced localized myxoid liposarcoma
- (2011) A. Gronchi et al. ANNALS OF ONCOLOGY
- Predictive impact of DNA repair functionality on clinical outcome of advanced sarcoma patients treated with trabectedin: A retrospective multicentric study
- (2011) P. Schöffski et al. EUROPEAN JOURNAL OF CANCER
- Trabectedin in advanced uterine leiomyosarcomas: A retrospective case series analysis from two reference centers
- (2011) Roberta Sanfilippo et al. GYNECOLOGIC ONCOLOGY
- A phase II evaluation of trabectedin in the treatment of advanced, persistent, or recurrent uterine leiomyosarcoma: A gynecologic oncology group study
- (2011) Bradley J. Monk et al. GYNECOLOGIC ONCOLOGY
- Antitumor and Anti-inflammatory Effects of Trabectedin on Human Myxoid Liposarcoma Cells
- (2010) G. Germano et al. CANCER RESEARCH
- A Review of Trabectedin (ET-743): A Unique Mechanism of Action
- (2010) Maurizio D'Incalci et al. MOLECULAR CANCER THERAPEUTICS
- Phase I and Pharmacokinetic Study of Trabectedin as a 1- or 3-hour Infusion Weekly in Patients with Advanced Solid Malignancies
- (2009) B. Forouzesh et al. CLINICAL CANCER RESEARCH
- Phase I clinical and pharmacokinetic study of trabectedin and cisplatin in solid tumours
- (2009) C. Sessa et al. EUROPEAN JOURNAL OF CANCER
- Efficacy and Safety of Trabectedin in Patients With Advanced or Metastatic Liposarcoma or Leiomyosarcoma After Failure of Prior Anthracyclines and Ifosfamide: Results of a Randomized Phase II Study of Two Different Schedules
- (2009) George D. Demetri et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase I study of the safety and pharmacokinetics of trabectedin in combination with pegylated liposomal doxorubicin in patients with advanced malignancies
- (2008) M. von Mehren et al. ANNALS OF ONCOLOGY
- Phase I trial of weekly trabectedin (ET-743) and gemcitabine in patients with advanced solid tumors
- (2008) Wells A. Messersmith et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Phase I Combination Study of Trabectedin and Doxorubicin in Patients with Soft-Tissue Sarcoma
- (2008) J.-Y. Blay et al. CLINICAL CANCER RESEARCH
- Phase I clinical and pharmacokinetic study of trabectedin and doxorubicin in advanced soft tissue sarcoma and breast cancer
- (2008) C. Sessa et al. EUROPEAN JOURNAL OF CANCER
- Transcription-coupled DNA Double-Strand Breaks Are Mediated via the Nucleotide Excision Repair and the Mre11-Rad50-Nbs1 Complex
- (2008) Josée Guirouilh-Barbat et al. MOLECULAR BIOLOGY OF THE CELL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search